Global X Genomics & Biotechnology ETF (GNOM) Short Interest Ratio & Short Volume $8.35 -0.16 (-1.88%) Closing price 03/28/2025 03:49 PM EasternExtended Trading$8.58 +0.23 (+2.75%) As of 03/28/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Genomics & Biotechnology ETF Short Interest DataGlobal X Genomics & Biotechnology ETF (GNOM) has a short interest of 16,400 shares, representing 0.25% of the float (the number of shares available for trading by the public). This marks a 30.16% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 60,071 shares to cover all short positions.Current Short Interest16,400 sharesPrevious Short Interest12,600 sharesChange Vs. Previous Month+30.16%Dollar Volume Sold Short$144,976.00Short Interest Ratio0.2 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares6,970,000 sharesShort Percent of Float0.25%Today's Trading Volume66,880 sharesAverage Trading Volume60,071 sharesToday's Volume Vs. Average111% Short Selling Global X Genomics & Biotechnology ETF? Sign up to receive the latest short interest report for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNOM Short Interest Over TimeGNOM Days to Cover Over TimeGNOM Percentage of Float Shorted Over Time Remove Ads Global X Genomics & Biotechnology ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202516,400 shares $144,976.00 +30.2%0.3%0.2 $8.84 2/28/202512,600 shares $116,298.00 -40.0%0.2%0.2 $9.23 2/15/202521,000 shares $208,110.00 +65.4%0.3%0.3 $9.91 1/31/202512,700 shares $129,286.00 -13.0%N/A0.2 $10.18 1/15/202514,600 shares $141,036.00 -45.3%N/A0.2 $9.66 12/31/202426,700 shares $259,257.00 -20.1%N/A0.4 $9.71 12/15/202433,400 shares $343,018.00 +62.1%N/A0.6 $10.27 11/30/202420,600 shares $223,304.00 +174.7%N/A0.5 $10.84 11/15/20247,500 shares $72,375.00 -44.0%N/A0.2 $9.65 10/31/202413,400 shares $139,092.00 -21.2%N/A0.3 $10.38 Get the Latest News and Ratings for GNOM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 10/15/202417,000 shares $186,660.00 -7.1%N/A0.4 $10.98 9/30/202418,300 shares $205,875.00 +21.2%N/A0.3 $11.25 9/15/202415,100 shares $171,243.06 -41.5%N/A0.3 $11.34 8/31/202425,800 shares $293,604.00 +6.6%N/A0.5 $11.38 8/15/202424,200 shares $273,387.40 +70.4%N/A0.4 $11.30 7/31/202414,200 shares $165,146.00 -10.1%N/A0.3 $11.63 7/15/202415,800 shares $179,646.00 +47.7%N/A0.3 $11.37 6/30/202410,700 shares $111,708.00 -32.7%N/A0.2 $10.44 6/15/202415,900 shares $166,314.00 +62.2%N/A0.3 $10.46 5/31/20249,800 shares $99,470.00 -31.9%N/A0.2 $10.15 5/15/202414,400 shares $157,248.00 -22.6%N/A0.2 $10.92 4/30/202418,600 shares $183,210.00 +69.1%N/A0.2 $9.85 4/15/202411,000 shares $112,750.00 No ChangeN/A0.1 $10.25 3/31/202411,000 shares $125,180.00 -77.9%N/A0.2 $11.38 3/15/202449,800 shares $571,206.00 -12.0%N/A0.7 $11.47 2/29/202456,600 shares $678,068.00 +133.9%N/A0.7 $11.98 2/15/202424,200 shares $276,848.00 +15.8%N/A0.4 $11.44 1/31/202420,900 shares $224,675.00 -20.8%N/A0.3 $10.75 1/15/202426,400 shares $299,376.00 +80.8%N/A0.1 $11.34 12/31/202314,600 shares $168,748.26 -9.9%N/A0.1 $11.56 12/15/202316,200 shares $183,546.00 -61.6%N/A0.1 $11.33 11/30/202342,200 shares $439,724.00 +47.6%N/A0.1 $10.42 11/15/202328,600 shares $287,716.00 -41.3%N/A0.1 $10.06 10/31/202348,700 shares $430,995.00 -28.5%N/A0.2 $8.85 10/15/202368,100 shares $661,932.00 -14.8%N/A0.3 $9.72 9/30/202379,900 shares $812,583.00 +415.5%N/A0.4 $10.17 9/15/202315,500 shares $168,795.00 -95.9%N/A0.1 $10.89 8/31/2023374,700 shares $4.21 million +4,963.5%N/A3.5 $11.23 8/15/20237,400 shares $82,880.00 -54.9%N/A0.1 $11.20 7/31/202316,400 shares $201,228.00 -64.7%N/A0.2 $12.27Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.You MUST act before April 23rd 7/15/202346,400 shares $568,864.00 -32.0%N/A0.8 $12.26 6/30/202368,200 shares $826,584.00 +44.8%N/A0.9 $12.12 6/15/202347,100 shares $607,590.00 -32.2%N/A0.6 $12.90 5/31/202369,500 shares $849,290.00 +100.9%N/A0.8 $12.22 5/15/202334,600 shares $452,222.00 +16.1%N/A0.4 $13.07 4/30/202329,800 shares $365,348.00 -60.5%N/A0.3 $12.26 4/15/202375,400 shares $944,762.00 -26.7%N/A0.8 $12.53 3/31/2023102,800 shares $1.27 million +139.6%N/A1.1 $12.32 3/15/202342,900 shares $526,383.00 +29.2%N/A0.5 $12.27 2/28/202333,200 shares $419,316.00 -61.4%N/A0.3 $12.63 2/15/202386,100 shares $1.14 million -13.3%N/A0.9 $13.29 1/31/202399,300 shares $1.35 million -23.7%N/A1 $13.58 1/15/2023130,200 shares $1.77 million +45.0%N/A1.3 $13.60 12/30/202289,800 shares $1.14 million -15.1%N/A0.8 $12.65 12/15/2022105,800 shares $1.39 million +63.8%N/A1 $13.09 11/30/202264,600 shares $872,100.00 +36.6%N/A0.7 $13.50 11/15/202247,300 shares $648,956.00 +48.3%N/A0.5 $13.72 10/31/202231,900 shares $419,485.00 -55.8%N/A0.3 $13.15 10/15/202272,100 shares $876,015.00 No ChangeN/A0.7 $12.15 9/30/2022110,000 shares $1.38 million -60.7%N/A1 $12.55 9/15/2022279,900 shares $3.97 million +232.0%N/A2.2 $14.19 8/31/202284,300 shares $1.17 million -43.7%N/A0.6 $13.83 8/15/2022149,800 shares $2.44 million +22.0%N/A1.1 $16.28 7/31/2022122,800 shares $1.75 million -25.3%N/A0.6 $14.24 7/15/2022164,400 shares $2.32 million -23.2%N/A0.8 $14.09 6/30/2022214,100 shares $2.62 million +237.2%N/A1.1 $12.22 6/15/202263,500 shares $706,120.00 +56.0%N/A0.4 $11.12 5/31/202240,700 shares $488,400.00 +2.8%N/A0.3 $12.00 5/15/202239,600 shares $467,676.00 -44.2%N/A0.2 $11.81 4/30/202271,000 shares $904,540.00 +30.3%N/A0.7 $12.74 4/15/202254,500 shares $790,250.00 +16.2%N/A0.5 $14.50 3/31/202246,900 shares $704,907.00 -1.3%N/A0.4 $15.03 3/15/202247,500 shares $644,100.00 -57.7%N/A0.3 $13.56 2/28/2022112,300 shares $1.74 million +18.7%N/A0.8 $15.46 2/15/202294,600 shares $1.54 million -0.9%N/A0.7 $16.31 1/31/202295,500 shares $1.54 million +41.3%N/A0.7 $16.14 1/15/202267,600 shares $1.16 million -18.5%N/A0.5 $17.22 12/31/202182,900 shares $1.65 million +18.8%N/A0.7 $19.85 12/15/202169,800 shares $1.42 million -30.8%N/A0.7 $20.38 11/30/2021100,800 shares $2.08 million +72.9%N/A1.1 $20.62 11/15/202158,300 shares $1.23 million -20.6%N/A0.6 $21.02 10/29/202173,400 shares $1.57 million +1.4%N/A0.9 $21.43 10/15/202172,400 shares $1.55 million +11.9%N/A0.9 $21.46 9/30/202164,700 shares $1.43 million -55.8%N/A0.8 $22.14 9/15/2021146,200 shares $3.43 million +56.5%N/A1.6 $23.46 8/31/202193,400 shares $2.25 million -31.2%N/A1 $24.12 8/13/2021135,700 shares $3.12 million +18.8%N/A1.5 $22.98 7/30/2021114,200 shares $2.62 million +13.0%N/A1.3 $22.93 7/15/2021101,100 shares $2.29 million -14.7%N/A1.1 $22.64 6/30/2021118,500 shares $2.95 million -4.1%N/A1.2 $24.89Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.You MUST act before April 23rd 6/15/2021123,500 shares $2.82 million +17.6%N/A1.1 $22.83 5/28/2021105,000 shares $2.26 million -48.8%N/A1 $21.50 5/14/2021205,000 shares $4.05 million +42.7%N/A1.6 $19.75 4/30/2021143,700 shares $3.29 million -30.7%N/A0.9 $22.87 4/15/2021207,300 shares $4.67 million +33.1%N/A1.3 $22.55 3/31/2021155,800 shares $3.34 million -4.3%N/A0.9 $21.44 3/15/2021162,800 shares $3.82 million +59.9%N/A0.9 $23.45 2/26/2021101,800 shares $2.42 million -75.1%N/A0.6 $23.77 2/12/2021408,900 shares $11.23 million +228.2%N/A2.8 $27.47 1/29/2021124,600 shares $3.12 million -15.4%N/A1.1 $25.07 1/15/2021147,300 shares $3.88 million No ChangeN/A1.6 $26.32 GNOM Short Interest - Frequently Asked Questions What is Global X Genomics & Biotechnology ETF's current short interest? Short interest is the volume of Global X Genomics & Biotechnology ETF shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 16,400 shares of GNOM short. 0.25% of Global X Genomics & Biotechnology ETF's shares are currently sold short. Learn More on Global X Genomics & Biotechnology ETF's current short interest. What is a good short interest percentage for Global X Genomics & Biotechnology ETF? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.25% of Global X Genomics & Biotechnology ETF's floating shares are currently sold short. Is Global X Genomics & Biotechnology ETF's short interest increasing or decreasing? Global X Genomics & Biotechnology ETF saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 16,400 shares, an increase of 30.2% from the previous total of 12,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Global X Genomics & Biotechnology ETF's short interest compare to its competitors? 0.25% of Global X Genomics & Biotechnology ETF's shares are currently sold short. Here is how the short interest of companies compare to Global X Genomics & Biotechnology ETF: Tradr 2X Long Innovation ETF (13.50%), Procure Space ETF (3.66%), Tradr 2X Short Innovation Daily ETF (10.04%), Global X Aging Population ETF (0.04%), Tema Cardiovascular and Metabolics ETF (0.02%), Fidelity Disruptive Medicine ETF (0.00%), Fidelity Disruptive Communications ETF (0.01%), Tema Oncology ETF (0.08%), AOT Growth & Innovation ETF (0.04%), Siren Nasdaq NexGen Economy ETF (0.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Global X Genomics & Biotechnology ETF stock? Short selling GNOM is an investing strategy that aims to generate trading profit from Global X Genomics & Biotechnology ETF as its price is falling. GNOM shares are trading down $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Global X Genomics & Biotechnology ETF? A short squeeze for Global X Genomics & Biotechnology ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNOM, which in turn drives the price of the stock up even further. How often is Global X Genomics & Biotechnology ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNOM, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Tradr 2X Long Innovation ETF Short Squeeze Procure Space ETF Short Squeeze Tradr 2X Short Innovation Daily ETF Short Squeeze Global X Aging Population ETF Short Squeeze Tema Cardiovascular and Metabolics ETF Short Squeeze Fidelity Disruptive Medicine ETF Short Squeeze Fidelity Disruptive Communications ETF Short Squeeze Tema Oncology ETF Short Squeeze AOT Growth & Innovation ETF Short Squeeze Siren Nasdaq NexGen Economy ETF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNOM) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
